Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hereditary Angioedema Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hereditary Angioedema Therapeuticmarket, defines the market attractiveness level of Hereditary Angioedema Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hereditary Angioedema Therapeutic industry, describes the types of Hereditary Angioedema Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hereditary Angioedema Therapeutic market and the development prospects and opportunities of Hereditary Angioedema Therapeutic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hereditary Angioedema Therapeutic market in Chapter 13.
By Player:
Sanofi
Pharming Group NV
Novartis AG
Ionis Pharmaceuticals
CSL Limited
CENTOGENE AG
BIOCRYST PHARMACEUTICALS, INC
KalVista Pharmaceuticals
Takeda Pharmaceutical Company Limited
By Type:
Intravenous
Subcutaneous
Oral
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hereditary Angioedema Therapeutic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hereditary Angioedema Therapeutic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hereditary Angioedema Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hereditary Angioedema Therapeutic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hereditary Angioedema Therapeutic Market Analysis and Outlook to 2022
-
7.1 Global Hereditary Angioedema Therapeutic Consumption (2017-2022)
-
7.2 United States Hereditary Angioedema Therapeutic Consumption (2017-2022)
-
7.3 Europe Hereditary Angioedema Therapeutic Consumption (2017-2022)
-
7.4 China Hereditary Angioedema Therapeutic Consumption (2017-2022)
-
7.5 Japan Hereditary Angioedema Therapeutic Consumption (2017-2022)
-
7.6 India Hereditary Angioedema Therapeutic Consumption (2017-2022)
-
7.7 South Korea Hereditary Angioedema Therapeutic Consumption (2017-2022)
8 Region and Country-wise Hereditary Angioedema Therapeutic Market Analysis and Outlook to 2028
-
8.1 Global Hereditary Angioedema Therapeutic Consumption Forecast (2022-2028)
-
8.2 United States Hereditary Angioedema Therapeutic Consumption Forecast (2022-2028)
-
8.3 Europe Hereditary Angioedema Therapeutic Consumption Forecast (2022-2028)
-
8.4 China Hereditary Angioedema Therapeutic Consumption Forecast (2022-2028)
-
8.5 Japan Hereditary Angioedema Therapeutic Consumption Forecast (2022-2028)
-
8.6 India Hereditary Angioedema Therapeutic Consumption Forecast (2022-2028)
-
8.7 South Korea Hereditary Angioedema Therapeutic Consumption Forecast (2022-2028)
9 Global Hereditary Angioedema Therapeutic Market Outlook by Types and Applications to 2022
-
9.1 Global Hereditary Angioedema Therapeutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravenous Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Oral Consumption and Growth Rate (2017-2022)
-
9.2 Global Hereditary Angioedema Therapeutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Hereditary Angioedema Therapeutic Market Outlook by Types and Applications to 2028
-
10.1 Global Hereditary Angioedema Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hereditary Angioedema Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Hereditary Angioedema Therapeutic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hereditary Angioedema Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hereditary Angioedema Therapeutic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hereditary Angioedema Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hereditary Angioedema Therapeutic Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Hereditary Angioedema Therapeutic Product and Service
-
14.2 Pharming Group NV
-
14.2.1 Pharming Group NV Company Details
-
14.2.2 Pharming Group NV Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pharming Group NV Hereditary Angioedema Therapeutic Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Hereditary Angioedema Therapeutic Product and Service
-
14.4 Ionis Pharmaceuticals
-
14.4.1 Ionis Pharmaceuticals Company Details
-
14.4.2 Ionis Pharmaceuticals Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ionis Pharmaceuticals Hereditary Angioedema Therapeutic Product and Service
-
14.5 CSL Limited
-
14.5.1 CSL Limited Company Details
-
14.5.2 CSL Limited Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 CSL Limited Hereditary Angioedema Therapeutic Product and Service
-
14.6 CENTOGENE AG
-
14.6.1 CENTOGENE AG Company Details
-
14.6.2 CENTOGENE AG Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 CENTOGENE AG Hereditary Angioedema Therapeutic Product and Service
-
14.7 BIOCRYST PHARMACEUTICALS, INC
-
14.7.1 BIOCRYST PHARMACEUTICALS, INC Company Details
-
14.7.2 BIOCRYST PHARMACEUTICALS, INC Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 BIOCRYST PHARMACEUTICALS, INC Hereditary Angioedema Therapeutic Product and Service
-
14.8 KalVista Pharmaceuticals
-
14.8.1 KalVista Pharmaceuticals Company Details
-
14.8.2 KalVista Pharmaceuticals Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 KalVista Pharmaceuticals Hereditary Angioedema Therapeutic Product and Service
-
14.9 Takeda Pharmaceutical Company Limited
-
14.9.1 Takeda Pharmaceutical Company Limited Company Details
-
14.9.2 Takeda Pharmaceutical Company Limited Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Takeda Pharmaceutical Company Limited Hereditary Angioedema Therapeutic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hereditary Angioedema Therapeutic
-
Figure Hereditary Angioedema Therapeutic Picture
-
Table Global Hereditary Angioedema Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hereditary Angioedema Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hereditary Angioedema Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hereditary Angioedema Therapeutic Consumption by Country (2017-2022)
-
Figure United States Hereditary Angioedema Therapeutic Consumption and Growth Rate (2017-2022)
-
Table Europe Hereditary Angioedema Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure China Hereditary Angioedema Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Hereditary Angioedema Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure India Hereditary Angioedema Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hereditary Angioedema Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Hereditary Angioedema Therapeutic Consumption Forecast by Country (2022-2028)
-
Figure United States Hereditary Angioedema Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hereditary Angioedema Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hereditary Angioedema Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hereditary Angioedema Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hereditary Angioedema Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hereditary Angioedema Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hereditary Angioedema Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hereditary Angioedema Therapeutic Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Hereditary Angioedema Therapeutic Product and Service
-
Table Pharming Group NV (Foundation Year, Company Profile and etc.)
-
Table Pharming Group NV Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharming Group NV Hereditary Angioedema Therapeutic Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Hereditary Angioedema Therapeutic Product and Service
-
Table Ionis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ionis Pharmaceuticals Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ionis Pharmaceuticals Hereditary Angioedema Therapeutic Product and Service
-
Table CSL Limited (Foundation Year, Company Profile and etc.)
-
Table CSL Limited Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Hereditary Angioedema Therapeutic Product and Service
-
Table CENTOGENE AG (Foundation Year, Company Profile and etc.)
-
Table CENTOGENE AG Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table CENTOGENE AG Hereditary Angioedema Therapeutic Product and Service
-
Table BIOCRYST PHARMACEUTICALS, INC (Foundation Year, Company Profile and etc.)
-
Table BIOCRYST PHARMACEUTICALS, INC Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table BIOCRYST PHARMACEUTICALS, INC Hereditary Angioedema Therapeutic Product and Service
-
Table KalVista Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table KalVista Pharmaceuticals Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table KalVista Pharmaceuticals Hereditary Angioedema Therapeutic Product and Service
-
Table Takeda Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Limited Hereditary Angioedema Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Limited Hereditary Angioedema Therapeutic Product and Service
-
